Claus Bachert, MD, PhD / Cecelia Damask, DO - Managing CRSwNP With Biologic Therapies: A Global Dialogue

episode

CME in Minutes: Education in Primary Care not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

2026-09-24- KSR - Hour 1 1h 4m · 24 Sep 2026 · KSR

Sage Advice From Granny Bingo 19 min · 24 Sep 2026 · It's A Lot with Abbie Chatfield

Trump, Xi Begin State Visit, Oil Soars on Iran Threat, More 7 min · 24 Sep 2026 · Bloomberg News Now

The Podcast is Pregnant: Thursday, September 24th, 2026 1h 12m · 24 Sep 2026 · The Toast

Daniel Kinahan's podcast with James English due out on same day as next court appearance 9 min · 24 Sep 2026 · Crime World

NPR News: 09-24-2026 11AM EDT 5 min · 24 Sep 2026 · NPR News Now

Report any issue

Source

Recorded20 Dec 2024

Publisherc.answersincme.com ↗

Handlerec:10296255

Show notes

Please visit answersincme.com/KSU860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in otolaryngology discuss the role of biologic therapies in chronic rhinosinusitis with nasal polyps (CRSwNP). Upon completion of this activity, participants should be better able to: Recognize considerations for initiating treatment with a biologic therapy in patients with CRSwNP; Review the clinical implications of the latest efficacy and safety data for novel approved biologics in CRSwNP; and Outline strategies to optimize the use of biologics in patients with CRSwNP over the long term.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in